CELGENE UK HOLDINGS LIMITED

Company number 05262324

Date	Type	Description	View / Download
19 Mar 2024	AP01	Appointment of Guy Edward Oliver as a director on 11 March 2024	(2 pages)
18 Dec 2023	AA	Full accounts made up to 30 June 2023	(23 pages)
17 Nov 2023	TM01	Termination of appointment of John Scott Cooke as a director on 8 November 2023	(1 page)
17 Aug 2023	CS01	Confirmation statement made on 16 August 2023 with no updates	(3 pages)
06 Jul 2023	CH01	Director's details changed for Director Kimberly Mccutcheon Jablonski on 1 July 2023	(2 pages)
03 Jul 2023	PSC05	Change of details for Bristol-Myers Squibb Company as a person with significant control on 1 July 2023	(2 pages)
25 May 2023	AP01	Appointment of Annie Ong as a director on 21 April 2023	(2 pages)
23 May 2023	TM01	Termination of appointment of David Walter Pignolet as a director on 21 April 2023	(1 page)
27 Mar 2023	AA	Full accounts made up to 30 June 2022	(23 pages)
03 Oct 2022	TM01	Termination of appointment of Teresa Maria Vargas Quintas Campos as a director on 3 October 2022	(1 page)
16 Aug 2022	CS01	Confirmation statement made on 16 August 2022 with no updates	(3 pages)
10 Feb 2022	AP01	Appointment of Director Kimberly Mccutcheon Jablonski as a director on 19 January 2022	(2 pages)
09 Feb 2022	TM01	Termination of appointment of Katherine Reynolds Kelly as a director on 17 September 2021	(1 page)
05 Jan 2022	AA	Full accounts made up to 30 June 2021	(22 pages)
30 Aug 2021	CS01	Confirmation statement made on 16 August 2021 with no updates	(3 pages)
10 Aug 2021	AP01	Appointment of John Scott Cooke as a director on 20 July 2021	(2 pages)
26 Jul 2021	TM01	Termination of appointment of Lynelle B. Hoch as a director on 20 July 2021	(1 page)
15 Jun 2021	AA	Full accounts made up to 30 June 2020	(21 pages)
27 Sep 2020	CS01	Confirmation statement made on 16 August 2020 with no updates	(3 pages)
15 May 2020	PSC02	Notification of Bristol-Myers Squibb Company as a person with significant control on 20 November 2019	(2 pages)
15 May 2020	PSC07	Cessation of Celgene Corporation as a person with significant control on 20 November 2019	(1 page)
13 May 2020	AP01	Appointment of Katherine Reynolds Kelly as a director on 30 April 2020	(2 pages)
13 May 2020	AP01	Appointment of Lynelle B. Hoch as a director on 30 April 2020	(2 pages)
11 May 2020	AP01	Appointment of Teresa Maria Vargas Quintas Campos as a director on 30 April 2020	(2 pages)
11 May 2020	TM01	Termination of appointment of Nakisa Serry as a director on 30 April 2020	(1 page)